← Back to all trials
Recruiting
NCT05758688
PROton Therapy for Post Surgical Treatment of GYNecologic Cancer
Conditions: Cervical Cancer, Uterine Cancer, Endometrial Cancer
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 25
Sponsor: Abramson Cancer Center at Penn Medicine
Location: Virtua Health Voorhees Township New Jersey
Summary
This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-reported gastrointestinal (GI) toxicity using WP PBS PRT in the definitive treatment of gynecologic cancers in the post-surgical, adjuvant setting.
Eligibility Criteria
Inclusion Criteria:
* Histologically confirmed cervical or endometrial cancer
* Indication for adjuvant whole pelvic radiation therapy, with or without systemic therapy
* Age of 18 years or older
* Written informed consent
* ECOG of 0-2 within 3 months of enrolling
Exclusion Criteria:
* Prior course of pelvic radiation
* Metastatic disease outside of the pelvis
* Active inflammatory bowel disease
* Incapacity to provide informed consent
Source: ClinicalTrials.gov (NCT05758688). StuddyBuddy aggregates publicly available trial information.